Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Sun Pharma Advanced Research Company Ltd.
DescriptionBCR-ABL tyrosine kinase inhibitors
Molecular Target BCR-ABL tyrosine kinase (BCR-ABL)
Mechanism of ActionBCR-ABL tyrosine kinase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationChronic myelogenous leukemia (CML)
Indication DetailsTreat chronic myelogenous leukemia (CML)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today